[Antileishmanial activity of five 2- or 3- quinolines by enyne group]. 2006

M Seck, and J Desrivot, and C Bories, and P Loiseau, and X Franck, and R Hocquemiller, and B Figadere, and J F Peyrat, and O Provot, and J D Brion, and M Alami
Laboratoire de Chimie Organique et Thérapeutique, Faculté de Médecine de Pharmacie et d'Odonto-stomatologie, Université Cheikh Anta Diop, Dakar, Sénégal. matarsec@yahoo.fr

BACKGROUND Leishmaniasis is an emergent orphan disease because of its co-infection with HIV AIDS. We report herein the in vitro biological evalution of five news quinolines, 2- or 3- substituted by an enyne group against Leishmania donovani (MHOM/ET/L82/LV9). METHODS The quinolines has been synthesized by using a cross-coupling reaction between a chloroenyne and an organometallic coumpound in a presence of iron a "green" catalyst. Biological evalution is realized by a colorimetric method with the use of 3-(4,5-dimethylthiazol-2,5-diphényl)-tétrazolium bromide. RESULTS Determination of the inhibitory concentrations as well as the minimal inhibitory concentrations has shown that the substitution by an enyne group made it possible to have a more important antileishmanial activity. In addition, we have seen that the -2 or the -3 position of the enyne group had no influence in the antileishmanial activity. CONCLUSIONS Thus, we have shown the real interest of these quinolines which could be favourably compared with pentamidine, which is currently the reference product, and to consider the use of these quinolines in the treament of the leishmaniasis.

UI MeSH Term Description Entries
D007896 Leishmaniasis A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL). Leishmania Infection,Infection, Leishmania,Infections, Leishmania,Leishmania Infections,Leishmaniases
D011804 Quinolines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

M Seck, and J Desrivot, and C Bories, and P Loiseau, and X Franck, and R Hocquemiller, and B Figadere, and J F Peyrat, and O Provot, and J D Brion, and M Alami
March 2005, Antimicrobial agents and chemotherapy,
M Seck, and J Desrivot, and C Bories, and P Loiseau, and X Franck, and R Hocquemiller, and B Figadere, and J F Peyrat, and O Provot, and J D Brion, and M Alami
April 2022, Molecules (Basel, Switzerland),
M Seck, and J Desrivot, and C Bories, and P Loiseau, and X Franck, and R Hocquemiller, and B Figadere, and J F Peyrat, and O Provot, and J D Brion, and M Alami
August 2007, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
M Seck, and J Desrivot, and C Bories, and P Loiseau, and X Franck, and R Hocquemiller, and B Figadere, and J F Peyrat, and O Provot, and J D Brion, and M Alami
July 2019, Organic letters,
M Seck, and J Desrivot, and C Bories, and P Loiseau, and X Franck, and R Hocquemiller, and B Figadere, and J F Peyrat, and O Provot, and J D Brion, and M Alami
November 2013, European journal of medicinal chemistry,
M Seck, and J Desrivot, and C Bories, and P Loiseau, and X Franck, and R Hocquemiller, and B Figadere, and J F Peyrat, and O Provot, and J D Brion, and M Alami
March 2014, Pure and applied chemistry. Chimie pure et appliquee,
M Seck, and J Desrivot, and C Bories, and P Loiseau, and X Franck, and R Hocquemiller, and B Figadere, and J F Peyrat, and O Provot, and J D Brion, and M Alami
January 1991, Farmaco (Societa chimica italiana : 1989),
M Seck, and J Desrivot, and C Bories, and P Loiseau, and X Franck, and R Hocquemiller, and B Figadere, and J F Peyrat, and O Provot, and J D Brion, and M Alami
June 2007, Toxicology,
M Seck, and J Desrivot, and C Bories, and P Loiseau, and X Franck, and R Hocquemiller, and B Figadere, and J F Peyrat, and O Provot, and J D Brion, and M Alami
September 2020, Organic letters,
M Seck, and J Desrivot, and C Bories, and P Loiseau, and X Franck, and R Hocquemiller, and B Figadere, and J F Peyrat, and O Provot, and J D Brion, and M Alami
December 2002, Journal of enzyme inhibition and medicinal chemistry,
Copied contents to your clipboard!